Community participatory learning to prevent and control type 2 diabetes in rural Kabul
Official title: Engagement of coMmunity Through Participatory Learning and Action for cOntrol and preVEntion of Type II Diabetes and Its Risk Factors [EMPOWER-D-Afg]: Feasibility Trial in Rural Kabul-Afghanistan
Run by HealthNet Transcultural Psychosocial Organization · NCT07350694 · Data updated 2026-11-12
This project will try a community-led participatory learning and action program to prevent and control type 2 diabetes among adults living in rural Kabul.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 20 Years and up |
| Sex | All |
| Enrollment | 250 (estimated) |
| Sponsor | HealthNet Transcultural Psychosocial Organization Academic / other |
| Locations | 1 site (Kabul, Kabul) |
| Status | Recruiting |
| Started | December 24, 2024 |
| Main results expected | November 30, 2026 |
| Study ends | September 30, 2027 |
| Registry record updated | January 20, 2026 |
| Trial ID | NCT07350694 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults living in the selected rural clusters of Kabul who are aged 20 years or older (and aged 30+ for baseline and endline assessments) who can attend meetings and give consent are eligible.
✕Probably not a fit
People under the age cutoffs, those unable or unwilling to attend regular meetings or give consent, or those with health conditions that prevent active participation are unlikely to benefit from the intervention.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
The project adapts a Participatory Learning and Action (PLA) intervention proven in Bangladesh to the sociocultural and health system context of rural Kabul. Clusters in Kabul are randomized and adult community members will be invited to attend regular PLA group meetings led by local facilitators, with baseline and endline biomedical assessments. The intervention targets behaviors and community solutions to prevent progression from intermediate hyperglycaemia and to improve diabetes control, with outcomes compared between intervention and control clusters. Feasibility, acceptability, and preliminary changes in glycaemic measures and related risk factors will be measured.
Why it matters
Potential benefit: If successful, the approach could lower new cases of type 2 diabetes and improve glucose control in participating communities by changing behaviors and strengthening local support.
How similar studies have gone: A similar PLA intervention (the DMagic trial) showed effectiveness in rural Bangladesh, but PLA approaches have not previously been tested in rural Afghan communities.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * For intervention phase: Individuals aged 20 years and above. For baseline and endline assessments (before and after the intervention): Individuals aged 30 years and above. * Participants residing in the randomized clusters of Kabul, Afghanistan Individuals willing to participate in the study and provide consent. * All individuals with normoglycemia, intermediate hyperglycaemia, and diabetes are encouraged to participate. * Participants who can attend the scheduled meetings and interventions as per the study protocol. Exclusion Criteria: * For Intervention phase: Individuals below the age of 20 years. For baseline and endline assessments (before and after the intervention): individuals below the age of 30 years. * Individuals unwilling to provide consent for participation. * Participants with reported health conditions that may hinder their active involvement in the study. * Individuals with non-compliance with research protocols
Where it's running
-
HealthNet TPO, Afghanistan
Kabul, Kabul, Afghanistan Recruiting
Study contacts
- Principal investigator: Abdul Rahman Shahab, MPH — Deputy Country Director, HealthNet TPO, Afghanistan
- Study coordinator: Abdul Rahman Shahab, MPH
- Email: abdul.shahab@hntpo.org
- Phone: +93786611325
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Cardio-Metabolic Clinic care for adults with type 2 diabetes and cardiovascular disease
This trial tests whether a specialized Cardio-Metabolic Clinic can improve heart function and overall health for adults with type 2 diabetes and cardiovascular disease compared with usual care.
-
See if short-term supervised resistance training improves muscle health and function in frail older adults with type 2 diabetes
This study tests whether a brief, supervised resistance training program can improve skeletal muscle health and physical function in frail adults over 65 who have type 2 diabetes.
-
Empagliflozin, Metformin, or both for muscle energy in adults with type 2 diabetes
This study tests whether empagliflozin, metformin, or their combination can improve skeletal muscle oxidative capacity and microvascular reactivity in adults recently diagnosed with type 2 diabetes.
-
Perioperative Meditation Music for Type 2 Diabetes Patients Undergoing Elective Surgery
We’re testing whether playing self-selected meditation music around surgery helps adults with type 2 diabetes stay calm, sleep better, and keep blood sugar steadier.
-
How metformin works in people with or without the SLC16A11 risk variant
This study tests whether the SLC16A11 genetic variant changes how adults with type 2 diabetes respond to metformin over 6 months.
-
Remote-patient monitoring in diabetes care shows real-world outcomes
A real-world, pre-post observational study at Steno Diabetes Center Copenhagen tests whether adding remote-patient-monitoring within the EHR can maintain glycemic outcomes over two years for about 12,000 people with diabetes compared with prior ambulatory care.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.